Akebia Therapeutics, Inc. (AKBA) Insider Ownership

Historic Insider Ownership Trends

As of June 06, 2026, the three largest insider holders of AKBA are John P. Butler (Ceo And President, 3.37Mn shares), Steven Keith Burke (Svp, Chief Medical Officer, 948.43K shares), Erik Ostrowski (Svp, Cfo, Cbo Treasurer, 672.63K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Leanne M Zumwalt - 109,400 0 11 Jun, 2025
Michael W Rogers - 161,729 0 11 Jun, 2025
Adrian Adams - 200,500 0 11 Jun, 2025
Steven C Gilman - 152,830 0 11 Jun, 2025
John P. Butler Ceo And President 3,367,064 0 05 Mar, 2026
Nicole R. Hadas Svp, Chief Legal Officer 651,243 0 14 May, 2024
Cynthia Smith - 160,933 0 11 Jun, 2025
Steven Keith Burke Svp, Chief Medical Officer 948,432 0 04 Feb, 2026
Nicholas Grund Chief Commercial Officer 561,750 0 04 Feb, 2026
Michel Dahan Svp, Chief Operating Officer 672,092 0 14 May, 2024
David A Spellman Svp, Cfo And Treasurer 446,483 0 18 May, 2023
Erik Ostrowski Svp, Cfo, Cbo Treasurer 672,635 0 04 Feb, 2026
Dell Faulkingham Svp, Cco 173,841 0 02 Mar, 2022
Ellen Snow Svp, Cfo And Treasurer 519,300 0 02 Feb, 2024
Myles Wolf - 133,381 0 11 Jun, 2025
Violetta Cotreau Svp, Chief Accounting Officer 219,954 0 16 May, 2022
Ron Frieson - 129,500 0 11 Jun, 2025
Richard C Malabre Svp, Chief Accounting Officer 299,390 0 04 Feb, 2026
Carolyn M. Rucci Svp, Chief Legal Officer 588,378 0 04 Feb, 2026

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
01 Apr, 2026 Philip J. Vickers Stock Option (Right to buy) A 214,400 $0.00 214,400 D A
01 Apr, 2026 Philip J. Vickers Stock Option (Right to buy) A 214,400 $0.00 214,400 D A
04 Mar, 2026 John P. Butler Common Stock A 69,270 $1.25 3,367,064 D P
02 Feb, 2026 Steven Keith Burke Common Stock D 21,582 $1.39 994,508 D S
02 Feb, 2026 Richard C Malabre Common Stock D 36,142 $1.39 312,772 D S
02 Feb, 2026 Erik Ostrowski Common Stock D 34,951 $1.39 672,635 D S
02 Feb, 2026 Nicholas Grund Common Stock D 53,585 $1.39 592,994 D S
02 Feb, 2026 Erik Ostrowski Common Stock D 34,951 $1.39 672,635 D S
02 Feb, 2026 Carolyn M. Rucci Common Stock D 16,846 $1.39 641,304 D S
02 Feb, 2026 Nicholas Grund Common Stock D 53,585 $1.39 592,994 D S
02 Feb, 2026 Carolyn M. Rucci Common Stock D 16,846 $1.39 641,304 D S
02 Feb, 2026 John P. Butler Common Stock D 46,660 $1.39 3,417,189 D S
02 Feb, 2026 Richard C Malabre Common Stock D 36,142 $1.39 312,772 D S
02 Feb, 2026 Richard C Malabre Common Stock D 13,382 $1.39 299,390 D S
02 Feb, 2026 Carolyn M. Rucci Common Stock D 25,382 $1.39 615,922 D S
02 Feb, 2026 Steven Keith Burke Common Stock D 25,375 $1.39 969,133 D S
02 Feb, 2026 Richard C Malabre Common Stock D 13,382 $1.39 299,390 D S
02 Feb, 2026 Nicholas Grund Common Stock D 31,244 $1.39 561,750 D S
02 Feb, 2026 Nicholas Grund Common Stock D 31,244 $1.39 561,750 D S
02 Feb, 2026 Carolyn M. Rucci Common Stock D 25,382 $1.39 615,922 D S